Clinical Trials in Baltimore

Showing 10221-10240 of 23,476 trials

COMPLETEDPhase 1< 1 mile

Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET

NCT03542773

To use 18F-DCFPyL imaging agent and PET/CT to detect none prostate cancer solid malignancies and schwannoma tumors.

SchwannomasMalignant Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins38 participantsStarted Feb 2015

Baltimore, Maryland, United States

COMPLETEDPhase 3< 1 mile

S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia

NCT00492856

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as gemtuzumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Sometimes the cancer may not need more treatment until it progresses. In this case, observation may be sufficient. It is not yet known whether combination chemotherapy is more effective than observation when given as maintenance therapy in treating acute promyelocytic leukemia. PURPOSE: This randomized phase III trial is studying tretinoin, mercaptopurine, and methotrexate to see how well they work when given as maintenance therapy compared with observation after combination chemotherapy in treating patients with acute promyelocytic leukemia. (Randomization and observation group closed as of 8/15/10)

Leukemia

SWOG Cancer Research Network105 participantsStarted Jun 2007

Scottsdale, Arizona, United States • Roseville, California, United States • Sacramento, California, United States +207 more locations

Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET

S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia

Find Trials by Condition in Baltimore

Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

PReventing the EffectS of Intubation on DEglutition

Teenage Health and Wellness Study

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Telerehabilitation Following Ankle Fractures

Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition

A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults

Ruxolitinib for Adult T-Cell Leukemia

Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

Efficacy, Tolerability, and Safety of DFN-15

Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product

Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection

A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma

A Study of Long-Term Responders on Olaparib

A Study of Respiratory Muscle Strength in Patients With Late-onset Pompe Disease (LOPD)